Hypertension Clinical Trials

Showing 1581-1600 of 1,710 trials

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

NCT00699192

To characterize the safety, tolerability, and efficacy profile of amlodipine/valsartan 5/80 mg as compared to amlodipine/valsartan 5/40 mg (with optional titration to 5/80 mg) and amlodipine 5 mg monotherapy in elderly patients (≥ 65 years of age) with essential hypertension. All three regimens are expected to be well tolerated.

Hypertension

Novartis Pharmaceuticals965 participantsStarted May 2008

Brno, Czechia • Chrudim, Czechia • Hodonín, Czechia +15 more locations

TERMINATEDNA

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments

NCT01173939

The study is being conducted to compare the effect of standard treatment (target LDL-C level: \<120 mg/dL (JASGL 2007 target level)) and intensive treatment (target LDL-C level: \<70 mg/dL) in the prevention of major adverse cardiac events (MACE) in hypercholesterolemia patients with concomitant type 2 diabetes and hypertension.

HypercholesterolemiaType 2 DiabetesHypertension

Positive Trial Group10,000 participantsStarted Jul 2010

Nagoya, Aichi Pref., Japan • Nagoya, Aichi Pref., Japan • Iyo Gun, Ehime Pref., Japan +314 more locations

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments

Related Searches

Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension

Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension

Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure

Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus

A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

CKD-828 (40/5mg) Pharmacokinetic Study

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet

Clinical Study of Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10 Standard

Coreg CR, Blood Vessel Stiffness and Blood Vessel Function

Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis

CKD-828(80/2.5mg) Pharmacokinetic Study

Whole Soy and Daidzein on Reduction of Blood Pressure in Postmenopausal Chinese Women